INRAE formalises SATT Aquitaine partnership
SATT Aquitaine has signed up INRAE and its tech transfer arm for a five-year agreement to help commercialise its research.
SATTs launch 97 spinouts in 2021
The network of regional tech transfer offices in France added a combined 97 new spinouts to their portfolios last year, bringing the total to 672.
Apollo rolls out red carpet for King's College
King’s College London has joined existing existing partners Imperial College London, University College London and University of Cambridge.
Orange Grove to harvest Korean opportunities
Orange Grove Bio has partnered SV Investment to jointly source therapeutics in South Korea and the US and create spinouts.
BeLab1407 brings $20m to UK universities
Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.
UTokyo takes Bird Initiative under its wing
UTokyo Innovation Fund has signed up to a new incubator that will form companies commercialising university-industry collaborations.
Idea Center signs up Saint Mary’s College
University of Notre Dame's commercialisation hub will help Saint Mary's College accelerate its tech transfer and entrepreneurship output.
Shoolini University seeks angel assistance
Chandigarh Angels Network has signed a memorandum of understanding to offer the Indian university's innovators early-stage funding and expertise.
Quebec looks to annex university TTOs
University of Montreal, Laval University and ETS are to combine their tech transfer operations within a Quebec-wide initiative due to launch next spring.
Revitope to revel in $10m investment
University of Birmingham's cancer immunotherapy developer Revitope Oncology secured equity funding as part of a $160m alliance with Junshi Biosciences.
UCLA collides with Autobahn Labs
UCLA has been named as the first university partner of an academic collaboration bridge backed by Evotec, Samsara BioCapital and KCK.
Axial Biotherapeutics realigns series B
Taiho Ventures has supplied a $10m extension for Caltech spinout Axial Biotherapeutics’ series B, bringing the total to $35m.
Parvus Therapeutics lands $800m in Genentech deal
University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.
UC Riverside partners Murrieta Genomics
UC Riverside has sealed an MOU with incubator Murrieta Genomics to drive its genomics research and build links between the innovation ecosystems of both parties.
No posts to show.